Carl L. Gordon, Director, 10% Owner at Compass Therapeutics, Inc. (CMPX), bought 402,000 shares at $3.21 ($1.3M) on 2022-11-08, disclosed to the SEC on 2022-11-10.
Open-market purchase of $1.3M CMPX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |